Skip to main content
Premium Trial:

Request an Annual Quote

NCI Approves New $104M Clinical Proteomics Technologies Initiative

NEW YORK, July 1 (GenomeWeb News) - The National Cancer Institute's Board of Scientific Advisors has approved a five-year, $104 million budget for a new program aimed at optimizing current proteomic technologies.

 

The program, called the Clinical Proteomics Technologies Initiative, hopes to optimize current proteomic technologies by improving reproducibility, standardization of data formats, throughput capabilities, sample preparation and handling, sensitivity, and specificity.

 

In addition, the program aims to develop new technologies, reagents, systems, and working consortia to advance the field of cancer proteomics research. Funding for the program will be given out over five years.

 

According to Gregory Downing, the director of NCI's Office of Technology and Industrial Relations, the NCI will issue requests for applications and request for proposals for the new program in the fall.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.